Decentralized clinical trials in a post COVID-19 world are undoubtedly here to stay. Recent events have had a drastic effect that is likely lasting as it relates to trials at the site levels. This can be a positive thing. Much of what sites can do now is prepare for this new future and VirTrial's Senior Vice President of Business Development, Amanda Rangel talks with us about just that. There is much to do, and now is the time to do it so that you are ready for what is coming and the future of clinical trials.